Restriction-fragment-length polymorphism in insulin-receptor gene and insulin resistance in NIDDM

Diabetes. 1988 Aug;37(8):1071-5. doi: 10.2337/diab.37.8.1071.

Abstract

Restriction-enzyme analysis of genomic DNA from 52 White and Hispanic nondiabetic subjects and 51 subjects with non-insulin-dependent diabetes (NIDDM) was carried out with insulin-receptor cDNA probes. A polymorphic 5.8-kilobase SstI fragment was found in 12 (23.5%) of 51 NIDDM subjects but only in 4 (7.7%) of 52 nondiabetic control subjects. This association is significant by chi 2-analysis (P less than .05). Furthermore, the nondiabetic subjects with the polymorphism were found to have hyperinsulinemia and/or nondiagnostic glucose tolerance. The polymorphism is a genetic marker for a phenotype that is neither necessary nor, by itself, sufficient for NIDDM. Nevertheless, it may indicate that insulin resistance functionally related to an insulin-receptor gene polymorphism is the proximal cause of NIDDM in at least one subset of the population.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Diabetes Mellitus, Type 2 / genetics*
  • Genes*
  • Humans
  • Insulin Resistance / genetics*
  • Middle Aged
  • Polymorphism, Genetic*
  • Polymorphism, Restriction Fragment Length*
  • Receptor, Insulin / analysis*

Substances

  • Receptor, Insulin